PreventiveRx Enhanced Drug List (Basic Plus Plan)
List of prescription preventive drugs covered (at low or no cost depending on benefit) under the PreventiveRx Enhanced Drug List for the Basic Plus / Essential Direct Drug List; affects members of the plan and providers submitting prescriptions in North Carolina.
No material clinical or coverage changes in this revision.
Coverage Criteria
This PreventiveRx Enhanced Drug List covers prescription preventive medications provided under the Basic Plus / Essential Direct Drug List in North Carolina. The list is intended to identify drugs used to prevent illness and maintain health and includes only prescription products; coverage and member cost depend on the member’s benefit and Certificate of Coverage. Brand-name drugs that have a generic equivalent available are not covered under this PreventiveRx benefit.
Certain diabetes-related devices and supplies are specifically excluded or limited from PreventiveRx coverage. Continuous Glucose Monitors (CGMs) are not included in PreventiveRx coverage. Blood glucose meters and test strips are covered only for specified manufacturers, and diabetic supplies require a prescription to be covered.
Provider Actions and Billing Rules
Prescription required; limited supplier/brand coverage
Diabetic supplies (blood glucose meters, test strips, and lancets) require a valid prescription to be covered by this plan. Only Accu-Chek and FreeStyle blood glucose meters and test strips are covered under this benefit. Continuous Glucose Monitors (CGMs) are not covered under PreventiveRx.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.